Clozapine pharmacology and tardive dyskinesia.

Psychopharmacology
J A LiebermanJ M Kane

Abstract

Clozapine, an atypical neuroleptic, does not cause extrapyramidal symptoms of Parkinsonism and dystonia and appears to have a reduced or absent capacity to produce tardive dyskinesia. 37 subjects, most with chronic schizophrenia, were treated with clozapine and TD outcome was analyzed. A subset of these subjects underwent plasma and CSF studies. TD response was heterogenous, but a proportion of patients improved with clozapine treatment. Neurochemical data differed from published reports of classical neuroleptics with the most robust effect produced by clozapine seen in CSF norepinephrine levels. Other neurochemical data and implications for the mechanism of clozapine in TD are reviewed.

References

Apr 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·J A LiebermanJ Kane
Jan 1, 1989·Psychopharmacology·J LiebermanJ Kane
Jan 1, 1986·Clinical Neuropharmacology·A N LiebermanM Goldstein
Jan 1, 1970·Acta Psychiatrica Scandinavica. Supplementum·G M Simpson, J W Angus
Nov 1, 1982·Acta Psychiatrica Scandinavica·W F GattazH Beckmann
Oct 30, 1984·European Journal of Pharmacology·R L FriedmanR L Barrett
Feb 26, 1998·Journal of Affective Disorders·E H UhlenhuthA M Swiontek

❮ Previous
Next ❯

Citations

Nov 1, 1994·Progress in Neuro-psychopharmacology & Biological Psychiatry·G ChouinardR Miller
Jan 1, 1993·Brain Research Bulletin·S R Graham, L Kokkinidis
Dec 23, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Patricia A BroderickYueping Zhou
Nov 1, 1996·Progress in Neuro-psychopharmacology & Biological Psychiatry·M G Juarez-ReyesW A Hargreaves
Jun 17, 2003·Journal of the American Medical Directors Association·Richard J Goldberg
Jun 17, 2003·Journal of the American Medical Directors Association·Richard J Goldberg
Jan 1, 1994·Journal of the American Academy of Child and Adolescent Psychiatry·T MozesA Weizman
Jan 1, 1994·Journal of Neural Transmission. General Section·A ThielE Rüther
Nov 20, 2001·International Clinical Psychopharmacology·O UzunA Ozsahin
Jan 27, 2011·The Pharmacogenomics Journal·A K TiwariJ L Kennedy
Feb 7, 2007·Current Opinion in Psychiatry·Gary Remington
Jan 1, 1989·Psychopharmacology·J LiebermanJ Kane
Jan 27, 2006·The Cochrane Database of Systematic Reviews·K Soares-Weiser, J Rathbone
Aug 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·G StoppeE Rüther
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Adib EssaliJohn Rathbone
Feb 7, 2018·The Cochrane Database of Systematic Reviews·Hanna BergmanKarla Soares-Weiser
Sep 1, 1992·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·E J CollinsM D Teehan
Apr 1, 1996·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·G J RemingtonG W MacEwan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here